Quick Summary
- Ark Invest purchased more than 705K shares of Rocket Lab valued at approximately $45M, positioning space technology as its primary investment focus
- The firm acquired 28,589 shares of Robinhood Markets valued at $3.5M, marking a shift after previous divestments as shares surged over 30% recently
- Major divestments included Palantir at $25M and Tempus AI at $27.7M across various funds
- Daily revenue from Robinhood Chain soared from under $200K to $4M in early September, leading Deutsche Bank to increase its target price to $136
- The Ark Innovation ETF shows a negative five-year annualized return of -7.02%, lagging behind the S&P 500’s 11.22% performance during the identical timeframe
Cathie Wood’s investment management firm, Ark Invest, executed several notable portfolio adjustments during the previous week, increasing positions in space exploration, financial technology, cryptocurrency, and biotechnology sectors while reducing exposure to technology and healthcare companies.
Ark’s Primary Acquisitions
The aerospace sector dominated the firm’s investment strategy. Ark acquired more than 705,000 shares of Rocket Lab valued at approximately $45 million. Within the fintech space, Ark purchased 456,000 shares of Block totaling roughly $37 million.
Additionally, Ark purchased 28,589 shares of Robinhood Markets valued at approximately $3.5 million. This acquisition marked a reversal from recent selling activity, which included offloading 25,009 shares on August 26 and more substantial sales during July.
Within the biotechnology sector, Ark added 274,000 shares of Intellia Therapeutics worth approximately $3.5 million, alongside smaller investments in Veracyte, Guardant Health, and Scribe Therapeutics.
For cryptocurrency exposure, Ark acquired 35,000 shares of Circle Internet Group worth roughly $3.3 million and established a position in the 3iQ Solana Staking ETF.
Portfolio Reductions
Ark’s most significant reductions occurred within technology and healthcare holdings. Palantir Technologies was reduced by $25 million. Shopify positions were trimmed by $23.6 million and Advanced Micro Devices by $8.1 million.
Within healthcare, Tempus AI was reduced by $27.7 million and Twist Bioscience by $11.9 million. Ark also decreased positions in Deere and Roblox by lesser amounts.
Robinhood and Bitcoin Connection
Robinhood shares have climbed more than 30% during the past month, correlating with Bitcoin’s 23% surge approaching $80,000. The stock had declined below $70 during the second quarter when Bitcoin fell to approximately $68,000.
Deutsche Bank analyst Brian Bedell increased his Robinhood price target to $136 from $115 on September 4, maintaining a buy recommendation. He highlighted robust expansion in Robinhood Chain, the company’s proprietary blockchain infrastructure.
Robinhood Chain generated daily revenue below $200,000 through mid-August. Revenue subsequently jumped to $3.38 million on September 1 and $4.01 million on September 2, based on DeFiLlama analytics.
Deutsche Bank currently projects Robinhood Chain revenue will surpass a $100 million annualized rate moving forward.
Robinhood currently ranks as the seventh largest position in Ark Innovation ETF, representing 4.28% of total assets.
Wood has publicly advocated for Bitcoin, describing it as “a technology revolution” and “a new global monetary system.” She suggested Bitcoin could function as both a risk-on and risk-off investment vehicle as innovative technologies transform the economic landscape.
Ark Innovation ETF has gained 12.09% year-to-date through September 4, marginally trailing the S&P 500’s 12.75% appreciation during the same timeframe. Over a five-year horizon, the fund has delivered a -7.02% annualized return, compared to 11.22% for the S&P 500.
The fund experienced approximately $1.71 billion in net redemptions during the 12-month period ending September 3.


